Company / Operating Income per Share
AbbVie Operating Income per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
$8.50
FY2025
5-year range
$5.14 / $12.08
FY2021-FY2025
Trend
+65.5%
vs FY2024
Sector context
#7 of 199
Health Care
What the data says
Among 199 Health Care companies, AbbVie is in the top 4% for operating income per share. Operating Income per Share returned to growth in FY2025 after 3 years of decline, reaching $8.50.
Based on SEC 10-K filings.
8.50 in FY2025 with a 5-year CAGR of +3.0%. Top quartile in the Health Care sector.
Improved from $7.18 to $8.50 over the past 2 years.
Health Care sector context is included.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -7.7%
- 5-Year CAGR
- +3.0%
- 10-Year CAGR
- -
Sector benchmark
Top 4% in Health CareTop 4% of 199This company $8.50 Sector average -$3.34
▼
+354.9% above sector average
Key checks
Key Insights
- In FY2025, operating income per share increased 65.5% year-over-year.
- Ranks #7 out of 199 companies in the Health Care sector.
- Peak operating income per share was recorded in FY2021.
- Lowest operating income per share in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score 0.62 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $8.50 | +65.5% |
| FY2024 | $5.14 | -28.4% |
| FY2023 | $7.18 | -33.7% |
| FY2022 | $10.83 | -10.3% |
| FY2021 | $12.08 | +64.3% |
| FY2020 | $7.35 | -9.3% |
| FY2019 | $8.10 | +107.0% |
| FY2018 | $3.91 | -32.9% |
| FY2017 | $5.83 | +0.5% |
| FY2016 | $5.80 | +23.5% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026